Reaven GM - Search Results

1

Relationship between plasma nitric oxide concentration and insulin resistance in essential hypertension.

Zavaroni I, Ardigo D, Rossi PC, Zuccarelli A, Pacetti E, Monti L, Piatti PM, Reaven GM. Zavaroni I, et al. Among authors: reaven gm. Am J Hypertens. 2004 Jul;17(7):549-52. doi: 10.1016/j.amjhyper.2004.02.009. Am J Hypertens. 2004. PMID: 15233972

2

Insulin resistance/compensatory hyperinsulinemia predict carotid intimal medial thickness in patients with essential hypertension.

Zavaroni I, Ardigò D, Zuccarelli A, Pacetti E, Piatti PM, Monti L, Valtueña S, Massironi P, Rossi PC, Reaven GM. Zavaroni I, et al. Among authors: reaven gm. Nutr Metab Cardiovasc Dis. 2006 Jan;16(1):22-7. doi: 10.1016/j.numecd.2004.11.003. Epub 2005 Jun 28. Nutr Metab Cardiovasc Dis. 2006. PMID: 16399488

3

Relation of plasma insulin levels to forearm flow-mediated dilatation in healthy volunteers.

Ardigo D, Franzini L, Valtuena S, Monti LD, Reaven GM, Zavaroni I. Ardigo D, et al. Among authors: reaven gm. Am J Cardiol. 2006 Apr 15;97(8):1250-4. doi: 10.1016/j.amjcard.2005.11.047. Epub 2006 Mar 3. Am J Cardiol. 2006. PMID: 16616036

4

The increase in plasma PAI-1 associated with insulin resistance may be mediated by the presence of hepatic steatosis.

Ardigò D, Franzini L, Valtueña S, Numeroso F, Piatti PM, Monti L, Reaven GM, Zavaroni I. Ardigò D, et al. Among authors: reaven gm. Atherosclerosis. 2010 Jan;208(1):240-5. doi: 10.1016/j.atherosclerosis.2009.06.026. Epub 2009 Jul 1. Atherosclerosis. 2010. PMID: 19656511

5

Insulin-resistance and associated risk factors for coronary heart disease as seen in families.

Zavaroni I, Reaven G. Zavaroni I, et al. Diabete Metab. 1991 May;17(1 Pt 2):109-11. Diabete Metab. 1991. PMID: 1936465 Review.

6

Hyperinsulinemia predicts hepatic fat content in healthy individuals with normal transaminase concentrations.

Ardigò D, Numeroso F, Valtueña S, Franzini L, Piatti PM, Monti L, Delsignore R, Reaven GM, Zavaroni I. Ardigò D, et al. Among authors: reaven gm. Metabolism. 2005 Dec;54(12):1566-70. doi: 10.1016/j.metabol.2005.05.027. Metabolism. 2005. PMID: 16311087

7

Alterations in nitric oxide/cyclic-GMP pathway in nondiabetic siblings of patients with type 2 diabetes.

Piatti PM, Monti LD, Zavaroni I, Valsecchi G, Van Phan C, Costa S, Conti M, Sandoli EP, Solerte B, Pozza G, Pontiroli AE, Reaven G. Piatti PM, et al. J Clin Endocrinol Metab. 2000 Jul;85(7):2416-20. doi: 10.1210/jcem.85.7.6667. J Clin Endocrinol Metab. 2000. PMID: 10902787 Clinical Trial.

8

Do coronary heart disease risk factors change over time?

Zavaroni I, Ardigo D, Massironi P, Gasparini P, Barilli AL, Vetrugno E, Sartori E, Baroni MC, Delsignore R, Reaven G. Zavaroni I, et al. Metabolism. 2002 Aug;51(8):1022-6. doi: 10.1053/meta.2002.34031. Metabolism. 2002. PMID: 12145776

9

Hyperinsulinemia and impaired leptin-adiponectin ratio associate with endothelial nitric oxide synthase polymorphisms in subjects with in-stent restenosis.

Galluccio E, Piatti P, Citterio L, Lucotti PC, Setola E, Cassina L, Oldani M, Zavaroni I, Bosi E, Colombo A, Alfieri O, Casari G, Reaven GM, Monti LD. Galluccio E, et al. Among authors: reaven gm. Am J Physiol Endocrinol Metab. 2008 May;294(5):E978-86. doi: 10.1152/ajpendo.00003.2008. Epub 2008 Mar 18. Am J Physiol Endocrinol Metab. 2008. PMID: 18349107 Free article.

10

Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension.

Lima NK, Abbasi F, Lamendola C, Reaven GM. Lima NK, et al. Among authors: reaven gm. Am J Hypertens. 2009 Jan;22(1):106-11. doi: 10.1038/ajh.2008.263. Epub 2008 Sep 4. Am J Hypertens. 2009. PMID: 18772854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

694 results

Search Page

Filters